Workflow
汤臣倍健(300146) - 2018 Q1 - 季度财报
By-healthBy-health(SZ:300146)2018-04-24 16:00

Financial Performance - Total revenue for Q1 2018 reached ¥1,067,528,780.45, representing a 45.03% increase compared to ¥736,054,794.77 in the same period last year[7] - Net profit attributable to shareholders was ¥372,090,907.60, up 31.39% from ¥283,198,485.82 year-on-year[7] - The net profit after deducting non-recurring gains and losses was ¥368,638,242.42, reflecting a 39.08% increase from ¥265,061,290.26 in the previous year[7] - Basic earnings per share increased to ¥0.25, a rise of 31.49% compared to ¥0.19 in the same period last year[7] - The company's revenue for the reporting period is 1,067.53 million RMB, an increase of 45.03% year-on-year, primarily due to sales growth[29] - The company's operating revenue for Q1 2018 was CNY 900.61 million, an increase of 50% compared to CNY 600.27 million in Q1 2017[70] - The net profit attributable to the parent company was CNY 372.09 million, up 31.4% from CNY 283.20 million in the same period last year[67] - The total profit for the quarter was CNY 495.25 million, representing a 40% increase from CNY 354.05 million in Q1 2017[66] Assets and Liabilities - Total assets at the end of the reporting period were ¥6,306,116,789.08, a 3.15% increase from ¥6,113,609,642.75 at the end of the previous year[7] - The total liabilities for the company at the end of the reporting period are significantly impacted by a 194.59% increase in tax payable, totaling 146.77 million RMB[28] - Total liabilities rose to ¥1,281,117,582.02, up from ¥981,649,965.51, marking a significant increase of 30.6%[58] - The total equity attributable to shareholders decreased to ¥4,984,948,909.42 from ¥5,100,825,081.79, a decline of 2.27%[59] Cash Flow - The company reported a net cash flow from operating activities of ¥121,997,320.18, a decrease of 2.89% from ¥125,629,256.35 in the previous year[7] - The company reported a cash inflow from operating activities of CNY 956.58 million, compared to CNY 661.47 million in the same period last year[71] - Operating cash inflow for Q1 2018 was CNY 992.53 million, up from CNY 688.18 million in Q1 2017, representing an increase of 44.3%[73] - The ending balance of cash and cash equivalents reached CNY 2.85 billion, up from CNY 2.22 billion at the end of Q1 2017[74] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 62,603[20] - The largest shareholder, Liang Yunchao, holds 48.36% of the shares, totaling 710,611,742 shares, with 37,000,000 shares pledged[20] - The total number of restricted shares at the end of the period is 593,404,547 shares, with no new restrictions added during the reporting period[23] Strategic Initiatives - The company is in the process of acquiring 100% of Life-Space Group Pty Ltd for no more than AUD 69 million, with the stock currently suspended pending approval[18] - The company is focusing on solidifying its big product strategy and launching e-commerce branding 2.0 strategy in 2018[32] - The company aims to expand into niche markets such as bone health and sports nutrition while enhancing its e-commerce branding efforts[30] - The company is planning to adjust its strategies for mergers and acquisitions under overall strategic guidance[32] - The company is committed to building a transparent factory and a nutrition exploration center as part of its branding efforts[32] - The company is actively pursuing cross-border e-commerce strategies to initiate a new growth cycle[30] Operational Efficiency - The company's operating costs for the reporting period are 345.78 million RMB, reflecting a year-on-year increase of 33.99% due to sales growth[29] - The accounts receivable at the end of the period is 277.21 million RMB, up 79.50% from the beginning of the year, attributed to increased sales and credit limits granted to customers[27] - The prepayment balance at the end of the period is 29.07 million RMB, up 111.52% from the beginning of the year, mainly due to increased advance payments to suppliers[27] - The company's tax expenses for the reporting period are 16.16 million RMB, an increase of 82.58% year-on-year, driven by revenue growth[29] - The company's investment income for the reporting period is 2.01 million RMB, a decrease of 93.34% year-on-year, mainly due to last year's equity transfer gains[29] Compliance and Governance - The company has not reported any non-compliance with external guarantees during the reporting period[51] - There are no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[43] - The company’s cash dividend policy is in line with regulatory requirements, with a distribution of RMB 3.30 per 10 shares approved for the 2017 fiscal year[50]